Naturhouse Health, S.A.
Madrid Stock ExchangeTotal Valuation
Naturhouse Health, S.A. carries a market capitalization of 152.87M, placing it among publicly traded companies globally. Its enterprise value stands at 75.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 152.87M |
| Enterprise Value | 75.07M |
Share Statistics
Naturhouse Health, S.A. currently has 59.95M shares outstanding.
| Shares Outstanding | 59.95M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Naturhouse Health, S.A. trades at a trailing price-to-earnings ratio of 9.91. The price-to-sales ratio is 1.69, and the price-to-book ratio stands at 7.51.
| PE Ratio | 9.91 |
| PS Ratio | 1.69 |
| PB Ratio | 7.51 |
| P/TBV Ratio | 3.71 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 1.36 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5.22 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.36 |
| EV / EBITDA | 5.22 |
| EV / EBIT | 5.22 |
| EV / FCF | N/A |
Financial Position
Naturhouse Health, S.A. maintains a current ratio of 3.44, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.44 |
| Quick Ratio | 2.22 |
| Debt / Equity | 14.20 |
| Debt / EBITDA | 0.26 |
| Interest Coverage | N/A |
Financial Efficiency
Naturhouse Health, S.A. posts a return on equity of 65.50 and a return on invested capital of 35.98.
| Return on Equity (ROE) | 65.50 |
| Return on Assets (ROA) | 23.41 |
| Return on Invested Capital (ROIC) | 35.98 |
| Return on Capital Employed (ROCE) | 46.67 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.30 |
Taxes
Over the trailing twelve months, Naturhouse Health, S.A. has paid 4.13M in income taxes, reflecting an effective tax rate of 30.54.
| Income Tax | 4.13M |
| Effective Tax Rate | 30.54 |
Stock Price Statistics
Naturhouse Health, S.A.'s stock has gained approximately 40.88398% over the past 52 weeks. The 50-day moving average sits at 2.55, while the 200-day moving average is 2.39.
| Beta (5Y) | N/A |
| 52-Week Price Change | 40.88398% |
| 50-Day Moving Average | 2.55 |
| 200-Day Moving Average | 2.39 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Naturhouse Health, S.A. generated 55.08M in revenue and converted that into 9.38M in net income, yielding earnings per share of 0.16. EBITDA reached 14.37M, while operating income came in at 14.37M.
| Revenue | 55.08M |
| Gross Profit | 39.21M |
| Operating Income | 14.37M |
| Pretax Income | 13.51M |
| Net Income | 9.38M |
| EBITDA | 14.37M |
| EBIT | 14.37M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
Naturhouse Health, S.A. holds 21.61M in cash and equivalents against 3.70M in total debt, resulting in a net debt position of -21.61M. Total book value stands at 12.38M, with working capital of 23.71M providing operational flexibility.
| Cash & Cash Equivalents | 21.61M |
| Total Debt | 3.70M |
| Net Debt | -21.61M |
| Equity (Book Value) | 12.38M |
| Book Value Per Share | 0.21 |
| Working Capital | 23.71M |
Margins
Naturhouse Health, S.A. operates with a gross margin of 71.18, reflecting its pricing power and cost economics. The operating margin of 26.09 and net profit margin of 17.03 provide insight into operational efficiency.
| Gross Margin | 71.18 |
| Operating Margin | 26.09 |
| Pretax Margin | 24.53 |
| Profit Margin | 17.03 |
| EBITDA Margin | 26.09 |
Scores
Naturhouse Health, S.A. posts an Altman Z-Score of 6.83, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.83 |